5-HT6 pharmacology inconsistencies

被引：18

作者：

Borsini, Franco ^{[1
]}

Bordi, Fabio ^{[1
]}

Riccioni, Teresa ^{[1
]}

机构：

[1] Sigma Tau Ind Farmaceut Riunite SPA, I-00040 Rome, Italy

来源：

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR | 2011年 / 98卷 / 02期

关键词：

5HT6; Receptors; MRNA; Neurochemistry and behavior; RECEPTOR ANTAGONIST SB-399885; MEDIAL PREFRONTAL CORTEX; BRAIN-PENETRANT; RAT-BRAIN; ANTISENSE OLIGONUCLEOTIDES; COGNITIVE IMPAIRMENT; MEDICINAL CHEMISTRY; RADIOLIGAND BINDING; WATER MAZE; RO; 04-6790;

D O I：

10.1016/j.pbb.2010.12.021

中图分类号：

B84 [心理学]; C [社会科学总论]; Q98 [人类学];

学科分类号：

03 ; 0303 ; 030303 ; 04 ; 0402 ;

摘要：

5-HT6 receptors are relatively recently-discovered receptors. After an uncertain beginning, where results were ambiguous, findings are now apparently more congruent. Nevertheless, discrepancies still exist. The aim of the present manuscript is to point out some of these discrepancies, in order to reflect on the current status of the field of the 5-HT6 receptor neuropharmacology, and where the field should move next. Examples of 5-HT6 receptor ligand-induced changes in behavior, neurochemistry and binding highlight areas where discrepancies remain and further experimental attention is needed. Possible methodological as well as conceptual issues underlying the inconsistencies are considered in an effort to increase awareness of the need for more thorough consideration of these aspects in future research. (C) 2010 Elsevier Inc. All rights reserved.

引用

页码：169 / 172

页数：4

共 67 条

[1] Bicyclic heteroarylpiperazines as selective brain penetrant 5-HT6 receptor antagonists [J].

Ahmed, M ;

Briggs, MA ;

Bromidge, SM ;

Buck, T ;

Campbell, L ;

Deeks, NJ ;

Garner, A ;

Gordon, L ;

Hamprecht, DW ;

Holland, V ;

Johnson, CN ;

Medhurst, AD ;

Mitchell, DJ ;

Moss, SF ;

Powles, J ;

Seal, JT ;

Stean, TO ;

Stemp, G ;

Thompson, M ;

Trail, B ;

Upton, N ;

Winborn, K ;

Witty, DR .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (21) :4867-4871

[2] Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats [J].

Arnt, Jorn ;

Bang-Andersen, Benny ;

Grayson, Ben ;

Bymaster, Franklin P. ;

Cohen, Michael P. ;

DeLapp, Neil W. ;

Giethlen, Bruno ;

Kreilgaard, Mads ;

McKinzie, David L. ;

Neill, Joanna C. ;

Nelson, David L. ;

Nielsen, Soren M. ;

Poulsen, Mette N. ;

Schaus, John M. ;

Witten, Louise M. .

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 (08) :1021-1033

[3]

Bentley J., 1997, J Psychopharmacol, V11, pA64

[4] Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04-6790, in rats [J].

Bentley, JC ;

Bourson, A ;

Boess, FG ;

Fone, KCF ;

Marsden, CA ;

Petit, N ;

Sleight, AJ .

BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (07) :1537-1542

[5] Functional and radioligand binding characterization of rat 5-HT6 receptors stably expressed in HEK293 cells [J].

Boess, FG ;

Monsma, FJ ;

Carolo, C ;

Meyer, V ;

Rudler, A ;

Zwingelstein, C ;

Sleight, AJ .

NEUROPHARMACOLOGY, 1997, 36 (4-5) :713-720

[6] The 5-hydroxytryptamine, receptor-selective radioligand [3H]Ro 63-0563 labels 5-hydroxytryptamine receptor binding sites in rat and porcine striatum [J].

Boess, FG ;

Riemer, C ;

Bös, M ;

Bentley, J ;

Bourson, A ;

Sleight, AJ .

MOLECULAR PHARMACOLOGY, 1998, 54 (03) :577-583

[7]

Borsini F, 2008, INT J NEUROPSYCHOPH, V11, P123

[8] 5-HT6 receptor antagonists:: lead optimisation and biological evaluation of N-aryl and N-heteroaryl 4-amino-benzene sulfonamides [J].

Bös, M ;

Sleight, AJ ;

Godel, T ;

Martin, JR ;

Riemer, C ;

Stadler, H .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2001, 36 (02) :165-178

[9]

BOURSON A, 1995, J PHARMACOL EXP THER, V274, P173

[10] 5-HT6 receptors as emerging targets for drug discovery [J].

Branchek, TA ;

Blackburn, TP .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2000, 40 :319-334

← 1 2 3 4 5 6 7 →